Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fphar.2026.1832803.s006IntroductionCardiac hypertrophy drives heart failure progression, with cardiomyocyte apoptosis playing a central role. Platycodin D (PLD), a bioactive saponin derived from Platycodon grandiflorum, exhibits cardioprotective properties, but its therapeutic potential and mechanisms in heart failure remain poorly understood.MethodsIn this study, we employed a mouse model of isoprenaline (ISO)-induced heart failure to investigate the therapeutic potential of PLD. Mice were administered PLD at doses of 12.5, 25, or 50 mg/kg/d for 4 weeks to evaluate its effects on cardiac function and hypertrophy. To elucidate the underlying mechanisms, we performed network pharmacology analysis, which identified p53 as a candidate target of PLD. The functional role of p53 was further assessed through pharmacological interventions, comparing the effects of PLD with those of the p53 inhibitor pifithrin-α (PFT-α) and examining whether p53 activation could abrogate PLD-mediated cardioprotection.ResultsPLD dose-dependently improved cardiac function and attenuated cardiac hypertrophy in ISO-induced HF mice. Network pharmacology and molecular docking identified p53 as a direct binding partner of PLD. PLD alleviated the apoptosis of cardiomyocyte by inhibition p53 depended on Bcl-2/Bax/caspase-3 signaling pathway. The cardioprotective effects of PLD were comparable to those of the p53 inhibitor pifithrin-α (PFT-α). But, these benefits were abolished upon p53 activation.ConclusionThis study demonstrates that PLD attenuates ISO-induced cardiac hypertrophy and heart failure by inhibiting the p53-mediated Bcl-2/Bax/caspase-3 apoptotic pathway. These findings establish PLD as a promising therapeutic candidate for heart failure.
Keyword(s):
cardiac hypertrophy; heart failure; network pharmacology analysis; p53; Pharmacology.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)